Latest News

The listing below shows our latest News Items and is updated regularly.  If you wish to post a news item please select the 'Post News' button on the right.  The displayed news feed starts on 1st August 2016.  Older items can be found here.

To 'Post Your News' use the button at the top right.

Rosalind Franklin Institute reaches key construction milestone

The Hub building which will house The Rosalind Franklin Institute on the Harwell Science and Innovation Campus has reached practical completion, with the construction company Mace handing legal ownership to UK Research and Innovation. The Franklin will now commence specialist scientific fit out.

The Franklin, funded through UK Research and Innovation’s Engineering and Physical Sciences Research Council, is dedicated to creating technologies which will change the way researchers see life. These technologies will be housed in the Hub at Harwell alongside 200 researchers, including collaborators from academia and industry.

Read the rest of entry »

Domainex expands executive team to support ongoing growth

Domainex Ltd., a leading provider of integrated drug discovery services, is pleased to welcome David Cronk, CBiol, MRSB, to the team as its new Chief of Staff. The Company has also promoted long standing team member and previous Head of Chemistry, Dr Ray Boffey, to Executive Director of Medicines Research. Following a successful period of growth and expansion of its research team, both David and Ray bring a wealth of drug discovery experience and will further support Domainex’s ongoing growth plans.

Read the rest of entry »

RSSL Webinar: Nitrosamines Analysis - Better Understanding the Risk

On 3rd February, RSSL's Daniel Nicolau will be speaking at a complimentary webinar considering the challenges of method development for nitrosamine analysis and the risk nitrosamines can pose.

Read the rest of entry »

Immunocore announces closing of $75.0 Million Series C round

Immunocore, a late-stage biotechnology company pioneering the development of a novel class of T cell receptor (TCR) bispecific immunotherapies designed to treat a broad range of diseases, including cancer, infectious and autoimmune disease, today announced the completion of a $75.0 million Series C private financing round.

Read the rest of entry »

Inivata’s First Patients Tested with InVisionFirst®-Lung in EORTC Sponsored Phase II NSCLC Study

Inivata, a leader in liquid biopsy, today announces that the first patients have been tested using InVisionFirst®-Lung as part of the Phase II ALKALINE trial sponsored by the European Organisation for Research and Treatment of Cancer (EORTC). As part of the study Inivata’s InVisionFirst-Lung liquid biopsy will be used to test and monitor ALK positive non-small cell lung cancer (NSCLC) patients initiating treatment with lorlatinib, Pfizer Inc.’s third generation ALK inhibitor therapy. 

Read the rest of entry »

AMSBIO: Cell Free Nucleic Acid Extraction

The cfPure® Cell Free DNA Extraction Kit from AMSBIO is a magnetic bead-based DNA extraction kit designed to isolate circulating cell free DNA (cfDNA) from human plasma or serum samples.

Read the rest of entry »

Yourgene Health: Clarigene® SARS-CoV-2 Product Update and Partnerships with CityDoc and ReCoVa-19

Yourgene (AIM: YGEN), the international molecular diagnostics group, announces that following the Company’s statement on 24 December 2020, regarding the new virus strain (VUI202012/01 SARS-CoV-2 variant), Yourgene’s wet lab testing is now complete and has confirmed that the performance of the Clarigene® SARS-CoV-2 assay is not impacted by any currently known mutations in the VUI202012/01 strain. 

Read the rest of entry »

Domainex invests in the Creoptix WAVEdelta to strengthen its fragment-based drug discovery platform

Domainex Ltd., a leading provider of integrated drug discovery services, is pleased to announce that it has invested in the WAVEdelta instrument from Creoptix AG. This instrument utilizes Grating-Coupled Interferometry (GCI) to measure target binding on sensor chips, generating binding affinity and on/off rate kinetics in a high throughput manner. This system achieves superior resolution in signal and time compared to traditional Surface Plasmon Resonance (SPR) and will further strengthen Domainex’s leading position in the fragment-based drug discovery field via its FragmentBuilder platform.

Read the rest of entry »

Hayes Parsons: A hardening insurance market - what does this mean for you?

Since the early 2000s, businesses have benefitted from a sustained period of "soft market" conditions within the insurance industry. This has markedly changed in the past 12 months and will likely deteriorate further, due to what's known as a "hardening" of the market.

Read the rest of entry »

University of Birmingham: New COVID-19 RNA test gives accurate results within minutes

University of Birmingham researchers have invented a COVID-19 test that reduces testing time from 30 minutes to under five, and delivers accurate results. 

Read the rest of entry »

Search Posts

News Policy

OBN aims to provide sector NEWS that is relevant to our Membership. We filter information from a variety of sources, publish items ourselves and will publish items of News from our Members. Press releases about OBN can be found here.